Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study

Oliva et al. (Thu,) studied this question.

www.synapsesocial.com/papers/68e6e8a8b6db64358766362f — DOI: https://doi.org/10.1007/s10096-024-04833-8

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis· 2017 · 6,023 citations
2. Quantitative Culture of Intravenous Catheters and Other Intravascular Inserts· 1980 · 377 citations
3. Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration· 2010 · 249 citations
4. Cefiderocol-containing regimens for the treatment of carbapenem-resistant <i>A. baumannii</i> ventilator-associated pneumonia: a propensity-weighted cohort study· 2023 · 36 citations
5. Acinetobacter baumannii in the critically ill: complex infections get complicated· 2023 · 106 citations